The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Feasibility and benefits of second-line chemotherapy in advanced biliary tract cancer: A large retrospective study.
Thomas Walter
No relevant relationships to disclose
Anne Horgan
No relevant relationships to disclose
Mairead Geraldine McNamara
No relevant relationships to disclose
Elizabeth McKeever
No relevant relationships to disclose
Trisha Min
No relevant relationships to disclose
David W Hedley
No relevant relationships to disclose
Stefano Serra
No relevant relationships to disclose
Monika K. Krzyzanowska
No relevant relationships to disclose
Eric Xueyu Chen
No relevant relationships to disclose
Helen Mackay
No relevant relationships to disclose
Ronald Feld
No relevant relationships to disclose
Malcolm J. Moore
No relevant relationships to disclose
Jennifer J. Knox
No relevant relationships to disclose